Biohacker Diagnosed with Rare Gastrointestinal Disorder
A biohacker in the United States, Mike Mudano, is grappling with an incurable and aggressive disease linked to his self-experimentation in pursuit of immortality. Mudano, a prominent figure in the biohacking community, has been injecting himself with unapproved gene therapies and other experimental treatments since 2017 to delay aging. However, he now suffers from a rare complication: a severe infection caused by *Pseudomonas aeruginosa*, a bacteria known for its resistance to antibiotics, which is eroding his stomach lining. Medical experts suggest his condition may be exacerbated by a compromised immune system resulting from his self-administered interventions.
Mudano’s case underscores the risks of unregulated biohacking, a growing movement where individuals alter their biology using DIY methods. While biohackers often cite personal autonomy and innovation as justifications, critics highlight the lack of scientific oversight and potential long-term health consequences. His infection, which has defied conventional treatments, has drawn attention from both the medical community and biohacking circles. The situation raises broader questions about the ethical and safety boundaries of human experimentation, particularly as regulatory bodies struggle to address the rise of self-directed biological research.
The controversy surrounding Mudano reflects a wider debate about the intersection of science, ethics, and individual choice. While some view biohacking as a frontier for human advancement, others warn of the dangers of bypassing clinical trials and safety protocols. As his health deteriorates, his story serves as a cautionary tale about the unpredictable outcomes of unverified medical self-experimentation, prompting calls for greater transparency and caution in the pursuit of radical life extension.